Ipamorelin is a synthetic pentapeptide and a selective agonist of the ghrelin/growth hormone secretagogue receptor (GHS-R1a). It was the first growth hormone releasing peptide (GHRP) receptor agonist developed with selectivity comparable to growth hormone releasing hormone (GHRH) for stimulating GH release, notably without significantly affecting cortisol, ACTH or prolactin levels. This selective secretagogue is utilized in studies focused on longevity markers, sleep regulation mechanisms and cellular renewal pathways. BPeptide’s Ipamorelin 10mg is supplied as a lyophilized powder and is verified for identity and purity by independent third party analysis.
Sleep Architecture Research
Used to study growth hormone pulsatility, which occurs predominantly during deep, slow wave sleep and its relationship to sleep regulation mechanisms.
Cellular Renewal Pathways
Researched for downstream growth hormone effects on cellular regeneration markers and systemic tissue repair processes.
Selective GHS-R1a Activation
Highly selective for GH secretion, distinguishing it from earlier generation GHRPs that also elevate cortisol and prolactin.
Longevity Marker Tracking
Applied in longitudinal research protocols observing restorative biological cycles relevant to longevity and aging research.




Reviews
There are no reviews yet.